← Open Payments lookup

MARIA HERNANDEZ-LOPEZ: Open Payments

NPI 1720102056 · COMMERCE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,963 in 39 payments from 11 companies in 2025. Trend: 2023 $2,061 · 2024 $2,283 · 2025 $2,963

Food & beverage: $2,851Education: $111
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc11$829
Teva Pharmaceuticals USA, Inc.10$597
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$503
Alkermes, Inc.6$264
Neurocrine BioSciences, Inc.2$264
Otsuka America Pharmaceutical, Inc.1$125
Janssen Biotech, Inc.1$123
E.R. Squibb & Sons, L.L.C.1$122
Vanda Pharmaceuticals Inc.1$100
Lundbeck LLC1$22

Products named: INVEGA SUSTENNA, CAPLYTA, UZEDY, INGREZZA, AUSTEDO XR, REXULTI, ARISTADA, LYBALVI.

Industry payments across CA — which companies pay providers there.